A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

BC Kuenen; P.O. Witteveen; G. Giaccone; A. Dontabhaktuni; F. Fox; T. Katz; H. Youssoufian; J. Zhu; E.K. Rowinsky; E.E. Voest

A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

BC Kuenen
, P.O. Witteveen
, G. Giaccone
, A. Dontabhaktuni
, F. Fox
, T. Katz
, H. Youssoufian
, J. Zhu
, E.K. Rowinsky
, E.E. Voest

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1915-1923
Number of pages	9
Journal	Clinical Cancer Research
Volume	16
Issue number	6
Publication status	Published - 2010

Cite this

@article{3c6409614f534ed485df234eb9c20c41,

title = "A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.",

author = "BC Kuenen and P.O. Witteveen and G. Giaccone and A. Dontabhaktuni and F. Fox and T. Katz and H. Youssoufian and J. Zhu and E.K. Rowinsky and E.E. Voest",

year = "2010",

language = "English",

volume = "16",

pages = "1915--1923",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

TY - JOUR

T1 - A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.

AU - Kuenen, BC

AU - Witteveen, P.O.

AU - Giaccone, G.

AU - Dontabhaktuni, A.

AU - Fox, F.

AU - Katz, T.

AU - Youssoufian, H.

AU - Zhu, J.

AU - Rowinsky, E.K.

AU - Voest, E.E.

PY - 2010

Y1 - 2010

M3 - Article

SN - 1078-0432

VL - 16

SP - 1915

EP - 1923

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 6

ER -